Literature DB >> 11679814

Comparison of the prevalence of inflammatory cells in subtypes of disc herniations and associations with straight leg raising.

J Virri1, M Grönblad, S Seitsalo, A Habtemariam, E Kääpä, E Karaharju.   

Abstract

STUDY
DESIGN: The prevalence of inflammatory cells in 205 disc herniations (DHs) and nine macroscopically normal discs for comparison was studied immunohistochemically. Inflammatory cells were separately analyzed in subtypes of DH. Immunohistochemical data were related to clinical parameters, the straight leg raising test (SLR) in particular.
OBJECTIVES: The objectives of the study were to compare the occurrence of inflammatory cells in various subtypes of DH and to determine the association between clinical data and inflammatory cell occurrence in a more extensive sample of DH, with separate analysis of DH subtypes. SUMMARY OF BACKGROUND DATA: Previous studies have suggested a common occurrence of inflammation and inflammatory cells, particularly macrophages, in DHs. No studies on any larger material comprising different subtypes of DH have been done.
METHODS: For immunohistochemistry the alkaline phosphatase antialkaline phosphatase method was used. Monoclonal antibodies to T cells in general (CD2), activated T cells (CD25), B cells (CD22), and macrophages (CD68) were used. Obtained immunostaining results were then compared with clinical data, e.g., duration of pain, SLR, and type of DH (sequesters 86, extrusions 103, protrusions 16). Associations were studied by the chi2 test or Fisher's exact test, as applicable (level of significance P < 0.05).
RESULTS: Abundant T cells were seen in 17% of the 205 DHs, activated T cells in 17%, B cells in 16%, and macrophages in 37%. All cell types were 2-3 times more prevalent in sequestrated discs than in extrusions. In protrusions macrophages were abundantly seen in 25% (4 of 16) and no other inflammatory cells. In patients with positive SLR and a sequestrated disc abundant lymphocytes were seen three times more often than in extrusions. When patients with bilaterally negative SLR were compared with those with tight SLR (< or =30 degrees ) with respect to inflammatory cell occurrence, some significant differences were noted (CD68, P < 0.025; CD25, P = 0.04). A comparison between SLR bilaterally positive and bilaterally negative also showed associations for all four inflammatory cell types (P = 0.016 to P = 0.029). There was no correlation between inflammatory cells and duration of pain. Abundant inflammatory cells were never seen in control discs.
CONCLUSIONS: When SLR was positive and the DH type was sequestered, inflammatory cells were most commonly seen. Our results showed some statistically significant associations between inflammatory cells and SLR, most clearly when comparing bilaterally positive and negative SLR. Interestingly, a bilaterally positive SLR showed an association with all four inflammatory cell types analyzed. Tight SLR also showed an association, particularly with macrophages. In addition to tissue resorption, they may participate in sciatic pain. Even though lymphocytes were less prevalent, they may have some role in sequestered discs and bilaterally positive SLR.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11679814     DOI: 10.1097/00007632-200111010-00004

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  16 in total

Review 1.  Pathobiology of Modic changes.

Authors:  Stefan Dudli; Aaron J Fields; Dino Samartzis; Jaro Karppinen; Jeffrey C Lotz
Journal:  Eur Spine J       Date:  2016-02-25       Impact factor: 3.134

2.  Plasmacytoid dendritic cells and memory T cells infiltrate true sequestrations stronger than subligamentous sequestrations: evidence from flow cytometric analysis of disc infiltrates.

Authors:  Andrea Geiss; Rolf Sobottke; Karl Stefan Delank; Peer Eysel
Journal:  Eur Spine J       Date:  2016-02-23       Impact factor: 3.134

Review 3.  The role of statins in neurosurgery.

Authors:  Jorge Humberto Tapia-Pérez; Martin Sanchez-Aguilar; Thomas Schneider
Journal:  Neurosurg Rev       Date:  2010-04-29       Impact factor: 3.042

4.  Can E-selectin be a reliable marker of inflammation in lumbar disc disease?

Authors:  Orhan Sen; M Volkan Aydin; Celal Bagdatoglu; M Eda Ertorer; Filiz Aka Bolat; Ozlem Yalcin; Hakan Caner; Nur Altinors
Journal:  Neurosurg Rev       Date:  2005-04-05       Impact factor: 3.042

5.  Therapeutic trial of fluoroscopic interlaminar epidural steroid injection for axial low back pain: effectiveness and outcome predictors.

Authors:  J W Lee; H I Shin; S Y Park; G Y Lee; H S Kang
Journal:  AJNR Am J Neuroradiol       Date:  2010-07-08       Impact factor: 3.825

Review 6.  Cytokine Involvement in Biological Inflammation Related to Degenerative Disorders of the Intervertebral Disk: A Narrative Review.

Authors:  Christopher M De Geer
Journal:  J Chiropr Med       Date:  2018-02-01

7.  An observation of massive lumbar disc prolapse.

Authors:  Edmond Chun Ying U; Anupkumar Shetty; Peter Richard Scott Craig; Shashank Dattatraya Chitgopkar
Journal:  J Spine Surg       Date:  2018-09

8.  Spontaneous regression of extruded lumbar disc herniation: three cases report.

Authors:  Sung Gon Kim; Joo Chul Yang; Tae Wan Kim; Kwan Ho Park
Journal:  Korean J Spine       Date:  2013-06-30

9.  Systemic Delivery of Bone Marrow Mesenchymal Stem Cells for In Situ Intervertebral Disc Regeneration.

Authors:  Carla Cunha; Catarina R Almeida; Maria Inês Almeida; Andreia M Silva; Maria Molinos; Sofia Lamas; Catarina L Pereira; Graciosa Q Teixeira; António T Monteiro; Susana G Santos; Raquel M Gonçalves; Mário A Barbosa
Journal:  Stem Cells Transl Med       Date:  2016-10-11       Impact factor: 6.940

10.  Clinical features as predictors of histologically confirmed inflammation in patients with lumbar disc herniation with associated radiculopathy.

Authors:  Jon J Ford; Omar Kaddour; Michael Gonzales; Patrick Page; Andrew J Hahne
Journal:  BMC Musculoskelet Disord       Date:  2020-08-21       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.